New **RESOURCE** in @natcancer.nature.com - a landmark single-cell Immune Atlas of multiple myeloma—1.3M+ bone marrow cells from 337 patients. Led by the Immune Atlas Consortium with major contributions from Sacha Gnjatic, @edgargk.bsky.social & HIMC profiling teams 🧐 www.nature.com/articles/s43...

🚀 NY-CURES Launch — Championing State-Wide Investment in Science! 🚀

Our new coalition advocates for sustained public support of New York’s vibrant biomedical research ecosystem — creating cures, economic gains & strengthening communities.

Sign up. Stay informed. Join the movement: www.nycures.org/

Scientists are working to shift from federal funding to state funding to facilitate identifying cures for multiple diseases with less bureaucracy. The first of its kind initiative 'Cures' New York State, register for free with your personal email ! nycures.org#support

What politician wants this: “Meals on Wheels x 100 with young people paid to cook and deliver meals.”

A multi-institutional phase 1 clinical trial exploring upfront multimodal standard of care and combined immunotherapies for newly diagnosed glioblastoma - PubMed These findings suggest the opportunity for patient stratification and the potential for more durable antitumor immune responses in future clinical trials of this multimodal standard of care and combin...

I'm excited to have been part of the correlative study for clinical trial NCT03576612 GMCI, Nivolumab, and Radiation Therapy in Treating Patients with Newly Diagnosed High-Grade Gliomas in a multicenter effort pubmed.ncbi.nlm.nih.gov/40120123/
@sinaiimmuno.bsky.social
@GnjaticLab

Fantastic Webinar series on Current Immuno-Oncology advances and includes outstanding Professors such as Sacha Gnjatic from @sinaiimmuno.bsky.social !

Read about one of recent studies about discovery of new biomarkers to improve treatment and diagnostics of endometrial cancer! @sinaiimmuno.bsky.social
www.mountsinai.org/about/newsro...